Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.

Mike BeckerNicole GrafRafael SauterYannick AllanoreJohn CurramChristopher P DentonDinesh KhannaMarco Matucci-CerinicJanethe de Oliveira PenaJanet E Pope Oliver Distlernull nullnull null

Published in: Annals of the rheumatic diseases (2019)

The use of the predictive factors presented here could enable cohort enrichment with patients at risk for overall disease worsening in SSc clinical trials.

Keyphrases

systemic sclerosis
interstitial lung disease
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
oxidative stress
peritoneal dialysis
randomized controlled trial
rheumatoid arthritis
low grade
open label